Brokerages expect Henry Schein, Inc. (NASDAQ:HSIC) to report $2.84 billion in sales for the current fiscal quarter, Zacks reports. Seven analysts have made estimates for Henry Schein's earnings, with estimates ranging from $2.72 billion to $2.97 billion. Henry Schein posted sales of $2.43 billion during the same quarter last year, which would suggest a positive year-over-year growth rate of 16.9%. The business is expected to announce its next earnings results on Tuesday, May 4th.
According to Zacks, analysts expect that Henry Schein will report full year sales of $11.62 billion for the current fiscal year, with estimates ranging from $11.06 billion to $12.37 billion. For the next year, analysts forecast that the firm will report sales of $11.81 billion, with estimates ranging from $11.26 billion to $12.86 billion. Zacks' sales calculations are an average based on a survey of research analysts that that provide coverage for Henry Schein.
Henry Schein (NASDAQ:HSIC) last released its earnings results on Tuesday, February 16th. The company reported $1.00 earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of $0.99 by $0.01. Henry Schein had a net margin of 6.14% and a return on equity of 11.60%. The company had revenue of $3.17 billion for the quarter, compared to the consensus estimate of $2.86 billion. During the same quarter in the previous year, the company earned $0.97 EPS.
A number of analysts have commented on HSIC shares. TheStreet lowered shares of Henry Schein from a "b" rating to a "c+" rating in a research note on Thursday, February 25th. Piper Sandler restated an "overweight" rating and set a $83.00 price target on shares of Henry Schein in a research note on Monday, February 8th. Robert W. Baird upgraded shares of Henry Schein from a "neutral" rating to an "outperform" rating and boosted their price target for the company from $70.00 to $79.00 in a research note on Monday, January 4th. Finally, Barrington Research boosted their price target on shares of Henry Schein from $72.00 to $80.00 and gave the company an "outperform" rating in a research note on Thursday, February 18th. One research analyst has rated the stock with a sell rating, two have given a hold rating and four have given a buy rating to the company's stock. The stock presently has an average rating of "Hold" and an average price target of $67.71.
Henry Schein stock opened at $68.67 on Friday. The company has a quick ratio of 0.92, a current ratio of 1.49 and a debt-to-equity ratio of 0.14. Henry Schein has a 12-month low of $49.83 and a 12-month high of $74.89. The firm's fifty day moving average is $65.91 and its 200 day moving average is $65.82. The company has a market capitalization of $9.77 billion, a PE ratio of 16.91, a PEG ratio of 3.12 and a beta of 0.86.
In other news, Director Deborah Derby bought 760 shares of Henry Schein stock in a transaction dated Wednesday, February 24th. The stock was purchased at an average price of $66.22 per share, for a total transaction of $50,327.20. The transaction was disclosed in a filing with the SEC, which is available through this link. Corporate insiders own 1.05% of the company's stock.
Several hedge funds and other institutional investors have recently bought and sold shares of HSIC. Perpetual Ltd bought a new stake in shares of Henry Schein in the 3rd quarter worth $38,000. WD Rutherford LLC bought a new position in Henry Schein during the fourth quarter valued at about $62,000. Chiron Capital Management LLC bought a new position in Henry Schein during the third quarter valued at about $71,000. First Horizon Advisors Inc. grew its position in Henry Schein by 1,087.4% during the fourth quarter. First Horizon Advisors Inc. now owns 1,318 shares of the company's stock valued at $88,000 after buying an additional 1,207 shares during the period. Finally, Vantage Consulting Group Inc bought a new position in Henry Schein during the fourth quarter valued at about $116,000. Hedge funds and other institutional investors own 94.73% of the company's stock.
Henry Schein Company Profile
Henry Schein, Inc engages in the provision of health care products and services to medical, dental, and veterinary office-based practitioners. It operates through the Healthcare Distribution, and Technology and Value-Added Services segments. The Healthcare Distribution segment includes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.
Recommended Story: Arbitrage
Get a free copy of the Zacks research report on Henry Schein (HSIC)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected]
Featured Article: Analyst Ratings7 Clean Energy Stocks With A Bright Future
The debate over renewable energy (i.e., clean energy) versus nonrenewable energy derived from fossil fuels was always going to come down to dollars and cents. Since 2016, things haven’t been easy for renewable energy companies. As the United States pushed towards energy independence, the Trump administration imposed tariffs on the industrial segments. The sector was subject to less favorable policies by electricity regulators. Plus, competing energy sources like coal received more help.
But a funny thing happened over the past four years. Renewable energy companies continued to grow. This is continuing a pattern that renewable sources of energy are becoming cost-competitive for businesses. And that is increasing demand.
One of the best parts of this sector for investors is that there are many ways to play the sector. In addition to solar and wind, hydrogen stocks are becoming an intriguing way to invest in renewable energy.
So rather than looking at this election as a choice between bad and good, investors should really be viewing it as a case of “good or better.” Because no matter who wins the election, clean energy stocks will continue to grow.
View the "7 Clean Energy Stocks With A Bright Future"